PartnershipJul 16, 2026, 08:02 AM
Callan JMB Partners with ASU for Pharma Ecosystem; $414M Revenue
AI Summary
Callan JMB Inc. announced a strategic partnership with Alabama State University (ASU) to develop an integrated pharmaceutical manufacturing ecosystem. This collaboration aims to strengthen domestic pharmaceutical production, enhance supply chain resilience, and advance workforce development. Callan JMB will provide operational infrastructure and expects to receive 21% of gross revenues from the initiative, which management believes could generate $414 million in five-year revenue and potentially $105 million in annual revenue for the company.
Key Highlights
- Callan JMB partnered with Alabama State University to develop a pharmaceutical manufacturing ecosystem.
- Management believes the initiative could represent a potential $414 million five-year revenue opportunity.
- Callan JMB would receive 21% of the gross revenue from qualifying pharmaceutical manufacturing operations.
- The initiative could generate annual gross revenues approaching $500 million.
- Callan JMB's 21% participation could represent approximately $105 million in annual revenue.
- Callan JMB will provide operational infrastructure including logistics, regulatory compliance, and warehousing.
Price Impact
More from CJMB